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ABSTRACT
Objective: To examine the association between
obese-years and the risk of cardiovascular disease
(CVD).
Study design: Prospective cohort study.
Setting: Boston, USA.
Participants: 5036 participants of the Framingham
Heart Study were examined.
Methods: Obese-years was calculated by multiplying
for each participant the number of body mass index
(BMI) units above 29 kg/m2 by the number of years
lived at that BMI during approximately 50 years of
follow-up. The association between obese-years and
CVD was analysed using time-dependent Cox
regression adjusted for potential confounders and
compared with other models using the Akaike
information criterion (AIC). The lowest AIC indicated
better fit.
Primary outcome: CVD.
Results: The median cumulative obese-years was 24
(range 2–556 obese-years). During 138 918 person-
years of follow-up, 2753 (55%) participants were
diagnosed with CVD. The incidence rates and adjusted
HR (AHR) for CVD increased with an increase in the
number of obese-years. AHR for the categories 1–24.9,
25–49.9, 50–74.9 and ≥75 obese-years were,
respectively, 1.31 (95% CI 1.15 to 1.48), 1.37 (95% CI
1.14 to 1.65), 1.62 (95% CI 1.32 to 1.99) and 1.80
(95% CI 1.54 to 2.10) compared with those who were
never obese (ie, had zero obese-years). The effect of
obese-years was stronger in males than females. For
every 10 unit increase in obese-years, the AHR of CVD
increased by 6% (95% CI 4% to 8%) for males and
3% (95% CI 2% to 4%) for females. The AIC was
lowest for the model containing obese-years compared
with models containing either the level of BMI or the
duration of obesity alone.
Conclusions: This study demonstrates that obese-
years metric conceptually captures the cumulative
damage of obesity on body systems, and is found to
provide slightly more precise estimation of the risk of
CVD than the level or duration of obesity alone.
BACKGROUND
The association between obesity and cardio-
vascular disease (CVD) is well known.1 2
However, these ﬁndings are generally based
on analysing only the level of body mass
index (BMI) in relation to CVD. Recently,
studies have demonstrated the importance of
taking into account the potential cumulative
effect of the duration of obesity, rather than
the simple assessment of obesity at a single
point in time (eg, at baseline). Duration of
obesity has been shown to be a risk factor for
CVD,3 type-2 diabetes4 and mortality,5 inde-
pendent of BMI. Nevertheless, analyses
based on either level of BMI alone or dur-
ation lived with obesity alone, may not reﬂect
the total effect of obesity and may underesti-
mate the risk of CVD attributable to obesity.
We have recently demonstrated the add-
itional beneﬁt of combining the level of
obesity with the number of years lived with
obesity into a single measure, ﬁnding that an
obese-years metric is a better predictor of the
risk of type-2 diabetes than level of BMI or
duration of obesity alone.6
The use of the obese-years metric to esti-
mate the risk of CVD has not been investi-
gated yet. We hypothesised that the
Strengths and limitations of this study
▪ The obese-years metric combines the number of
years lived with obesity and the level of body
mass index (BMI) to examine the total effect of
obesity.
▪ The Framingham Heart Study is a long-term pro-
spective cohort study with approximately
50 years of follow-up, and biennial measure-
ments of body weight, covariates and health
outcomes.
▪ By using time-dependent Cox proportional
hazards regression, the analysis takes into
account changes in covariates during study
follow-up and adjusts for a large number of
potential confounding variables.
▪ The obese-years metric was developed based on
the measurement of BMI. It is unclear whether
using anthropometric measures other than BMI
would produce different results.
▪ Data used for this study were from a relatively
old cohort study, which began in 1948.
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obese-years metric is likely a similar independent risk
factor for CVD and would provide an improved estima-
tion of the risk of future CVD. This study aimed to
examine the association between obese-years and risk of
CVD and to examine whether the obese-years metric is a
better predictor for risk of CVD than current BMI or
duration of obesity alone. We investigated these objec-
tives using the Framingham Heart Study (FHS), a long-
term prospective cohort study where body weight, health
outcomes and other covariates were measured biennially
for almost 50 years.7
METHODS
Data source
We used data from the FHS.8 In this prospective cohort
study, 5209 participants (aged 28–62 years at the time of
enrolment) attended biennial examinations for approxi-
mately 50 years beginning from 1948. For the purpose of
this study, only participants who were free from CVD
(any type), cancer and type-2 diabetes at baseline were
included in the analysis (n=5036).
Variables: measurement, missing and imputation
Most variables in the FHS were measured regularly at the
two yearly examinations, including body weight, height,
demographic variables, health behaviours and health out-
comes (including CVD).7 Some values are missing by
design where variables were not collected at every exam-
ination. For example, current smoking status was not
recorded at four examinations (2, 3, 6 and 17), choles-
terol was not measured at seven examinations (11, 12,
17–20 and 22), alcohol consumption was measured only
at eight examinations (2, 4, 7, 19 and 20–23), and phys-
ical activity was measured only at four examinations (4,
11, 12 and 19). In this circumstance, the most contem-
porary measured value of the variable was used in place
of missing values at the examination times when the vari-
able was not measured. Another missing data circum-
stance was when missing values occurred intermittently
during study follow-up; for example, body weight and
hence BMI. In this case missing values for BMI were
imputed with a conditional mean estimated by a multiple
linear regression model using age at prior examination,
sex and several transformations of the previously mea-
sured BMI (BMI, log BMI, BMI squared and BMI as a cat-
egorical variable). Methods of measurement of these
variables have been described in detail elsewhere.4 6
The level of obesity, duration and obese-years
measurement
Participants were considered obese at a given examin-
ation if their BMI was greater than or equal to 30 kg/m2.
The level of obesity was deﬁned as follows: (1) if BMI
<30 kg/m2, the level was zero; and (2) if BMI ≥30 kg/m2,
the level was BMI minus 29 kg/m2. For example, if BMI
was 35 kg/m2, the level was 6 (35–29) obese units.
The duration of obesity followed a similar deﬁnition
to that described previously.4 The duration of obesity
was calculated for those individuals with at least two con-
secutive examinations with occurrence of obesity (which
is interpreted as indicating at least 2 years of being con-
tinuously obese). The requirement for two consecutive
examinations with obesity was to avoid the potential mis-
classiﬁcation of body weight, either due to measurement
error or ﬂuctuations between the borderline of the
‘overweight’ category or the ‘obese’ category. For those
individuals without two consecutive obesity occurrences,
duration was considered to be zero at all examinations.
For those individuals with two consecutive obesity occur-
rences, the beginning of their obesity duration interval
was deﬁned as the date of the ﬁrst of these two examina-
tions and from that time, the individual was considered
to be continuously obese until either the ﬁrst of two con-
secutive non-obese examinations, or death, or the end
of follow-up at examination 24. Individuals could have
multiple periods of obesity duration during follow-up.
The level of obesity and the duration of obesity were
combined as a single variable called obese-years.
Obese-years was calculated at each examination as the
deﬁned level of obesity (in ‘obese units’) multiplied by
the deﬁned duration of obesity (in years). Then the
cumulative total of obese-years for each examination was
calculated as a sum of all obese-year ‘exposures’ up to
and including that examination.
Table 1 illustrates the calculation of obese-years for a
single individual. This participant ﬁrst had a measure-
ment of obesity at examination 2 and was assigned
obesity duration of zero at this examination. At examin-
ation 3, this participant was assumed to have lived with
obesity for 2 years (the interval between examinations 2
and 3) with a degree of obesity of 1 kg/m2. This
approach assumes that an individual’s BMI is carried
forward from a given examination (ie, examination 2)
and does not change until a different BMI value at a
subsequent examination (ie, examination 3). The
number of obese-years at examination 3 was therefore 2
obese-years (1 BMI unit×2 years in the preceding inter-
val). From examinations 3 to 4 (a 3-year interval), the
participant was still obese with a degree of obesity of
3 kg/m2 (BMI 32 kg/m2). At examination 4, the
number of obese-years was 9 (3 BMI unit×3 years) and
the cumulative obese-years at this examination was 11
obese-years (2 plus 9).
This method implies that individuals accumulating 50
obese-years, for example, could have reached this quan-
tity either by having been obese with BMI of 30 kg/m2
for approximately 50 years or by having been obese with
BMI of 34 kg/m2 for approximately 10 years or, indeed,
many other combinations.
Measurement of the outcome and time to event
The main outcome of interest in this study was CVD
incidence (the ﬁrst event of any type of CVD; deﬁned as
a composite of coronary heart disease (CHD),
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cerebrovascular accident (CVA), peripheral artery
disease and congestive heart failure (CHF)).9 Additional
outcomes were individual types of CVD: hard CVD,
CHD, CVA and CHF. Hard CVD was deﬁned as a com-
posite of hard CHD (coronary death, myocardial infarc-
tion), stroke (fatal and nonfatal), peripheral artery
disease and heart failure. In the FHS, the criteria for
each cardiovascular outcome during follow-up were stan-
dardised10 and a panel of Framingham investigators
made an adjudication regarding diagnosis. CHD
includes the diagnoses of (1) angina pectoris, evidenced
by a typical history of chest pain on a physician-
administered questionnaire; (2) myocardial infarction,
determined by speciﬁed ECG changes, diagnostic eleva-
tion of serum enzymes with prolonged ischaemic chest
pain, or on autopsy; (3) coronary insufﬁciency, deﬁned
as prolonged ischaemic chest pain accompanied by tran-
sient ischaemic abnormalities on ECG; and (4) sudden
(in less than 1 h) or non-sudden coronary death. CHF
was indicated when at least two major or one major and
two minor diagnostic conditions existed concurrently on
examination.
Time to event was measured as the time from cohort
entry until the date a participant was diagnosed as
having CVD. Individuals who died or reached the end of
the follow-up (examination 24) before developing CVD
were censored at date of death or examination 24,
respectively.
Data analysis
To model the relationship between the various measures
of obesity and risk of CVD in a dynamic survival model
way11 an extended Cox regression model involving time-
dependent (time-varying) variables12–15 was used. The
demographic and health behaviour variables included
in the analysis were age, sex and country of birth at base-
line, and the time-varying values of education level,
marital status, smoking status, alcohol consumption
(ounces/month) and physical activity. The regression
coefﬁcients from these models were exponentiated and
interpreted as HRs noting that care is required with this
interpretation14 since the model does not technically
deﬁne proportional hazards in the presence of time-
varying variables.
The obese-years metric was analysed as a continuous
and also as a categorical variable using the same categor-
ies used in the previous study6 for comparison purposes.
For analyses of continuous obese-years, HRs are pre-
sented per 10 obese-years. For analyses of categorical
obese-years, participants who were never obese during
study follow-up (zero obese-years) were assigned as a
comparator (reference category) and the level of obese-
years was grouped into short, medium long and exten-
sive periods representing 1–24.9, 25–49.9, 50–74.9 and
≥75 obese-years. HRs are presented as crude HRs as well
as multivariate-adjusted HRs for continuous and also cat-
egorical versions of obese-years. Three models were used
to examine the HRs with the addition of different con-
founding variables. Model 1 was adjusted for age. Model
2 was adjusted for age, sex, marital status, educational
level and country of birth. Model 3 included adjustment
for all variables in model 2 plus the health behaviour
variables of smoking status, alcohol consumption and
physical activity. The analyses were stratiﬁed by sex and a
test for interaction between sex/smoking status and
obese-years was performed.
To compare the relative predictive values of obesity
level, obesity duration and the obese-years metric, each
of these three variables was divided into an equal
number of categories. One group was created for those
who were never obese (BMI less than 30 kg/m2) as a ref-
erence. For those with obesity, 10 deciles were used to
create categories. The goodness of ﬁt of the models
incorporating each of the three variables was compared
using Akaike’s information criterion (AIC), computed as
−2 (log-likelihood) + 2 (number of estimated
Table 1 Illustration of the calculation of an obese-years metric for a single hypothetical individual
ID Examination
Interval between
examinations, years*
Body mass
index†
Degree of
obesity
Duration of
obesity, years Obese-years*
Cumulative
obese-years
6 1 (baseline) – 28 0 – 0 0
6 2 2 30 1 0 0 0
6 3 2 32 3 2 2 2
6 4 3 34 5 3 9 11
6 5 1 32 3 1 5 16
6 6 2 30 1 2 6 22
6 7 1.5 28 0 1.5 1.5 23.5
6 8 2.5 28 0 0 0 23.5
6 9 2 30 1 0 0 23.5
6 10 1.5 32 3 1.5 1.5 25
6 11 3 34 5 3 9 34
6 12 2 32 3 2 10 44
6 13 2 30 1 2 6 50
*All intervals refer to the interval between the current examination and the prior examination.
†Weight (kg)/height (m)2.
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parameters); with a lower AIC indicating a better ﬁt.16
All analyses were performed using the Stata statistical
software package V.11.0 (StataCorp, College Station,
Texas, USA).17
Sensitivity analyses
A sensitivity analysis was performed to examine whether
the associations were inﬂuenced by the imputation
method for missing BMI. The analysis was repeated by
including only participants with no missing values of
BMI at any examinations. The effect of the duration of
obesity prior to baseline was tested by excluding those
who were obese at baseline (n=576).
RESULTS
Characteristics of the participants
Of the 5036 eligible study participants, 1230 (24%) par-
ticipants were obese for at least two consecutive exami-
nations during the study follow-up. For those who were
ever obese during the study, the median cumulative dur-
ation of obesity was approximately 12 years (range 2–
46 years), and the median cumulative obese-years was 24
(range 2–556 obese-years). Two thousand seven
hundred ﬁfty-three (55%) participants were diagnosed
with CVD over approximately 138 918 person-years of
follow-up (table 2).
Incidence and HRs for CVD
The incidence rates and adjusted HR for CVD increased
with an increase in the number of obese-years (tables 3
and 4). In model 3 for males and females combined,
the adjusted HRs for the categories 1–24.9, 25–49.9, 50–
74.9 and ≥75 obese-years were, respectively, 1.31 (95%
CI 1.15 to 1.48), 1.37 (95% CI 1.14 to 1.65), 1.62 (95%
CI 1.32 to 1.99) and 1.80 (95% CI 1.54 to 2.10) com-
pared with those who were never obese (ie, had zero
obese-years). For obese-years as a continuous variable,
with every 10 unit increase in obese-years, the adjusted
HR for CVD was estimated to increase by 4% (95% CI
3% to 5%; table 5). There were no signiﬁcant interac-
tions between obese-year categories with sex or smoking
status. There was evidence of an interaction between
obese-years as a continuous variable and sex (p=0.01).
The effect of obese-years was stronger in males than in
females.
Comparing obesity metrics and AIC
Table 6 demonstrates the risk of CVD for each of the
three different constructs for obesity: level of obesity
(based on BMI), duration of obesity and the obese-years
metric. Each construct was analysed in a separate model
as an additive effect and the strength of association was
compared using the AIC. In all outcomes, the AIC was
lowest in the model using the obese-years metric com-
pared with the other models for the total population
and by sex.
Sensitivity analysis
The sensitivity analyses showed that the association
between obese-years and risk of CVD was similar in a
complete case analysis and the analysis using imputed
missing values for BMI. Exclusion of participants who
were obese at baseline showed only a slightly lower
adjusted HR: 1.03 (95% CI 1.01 to 1.05).
DISCUSSION
This study found that measuring the total effect of
obesity by combining the level and the duration of
obesity into a single metric of obese-years is a stronger
predictor for the risk of CVD compared with using dur-
ation of obesity or level of obesity alone. A clear
dose-response relationship between obese-years and risk
of CVD was observed. A stronger effect was found in
males than in females.
Although the HRs were very similar between the three
different constructs, and it is not possible to perform a
statistical comparison of discrimination between the
models due to the fact that they are non-nested, the AIC
does indicate that combining the level and duration of
obesity into a single construct of obese-years provides
greater discriminative power than a model with level of
obesity or obesity duration alone. However, the disparity
in AIC between the competing models was not as great
as was observed with diabetes as the outcome of inter-
est,6 and so it is unclear the extent to which this ﬁnding
has important implications for future studies of the total
health impact associated with obesity and whether
future studies should take into account the impact of
obesity level as well as changes in the duration of
obesity.
There are different ways to operationalise the impact
of excess weight over time. A recent systematic review
identiﬁed at least four models: an additive model, a
duration-of-obesity model, an additive-weight-change
model and an interactive model.18 In addition to these
models, ﬁndings using the obese-year model suggest
that analysing the combined effect of the duration and
the level of obesity as a predictor of CVD is worthwhile.
Such approaches add information over and above simply
the level of excess weight or length of time with obesity.
As has been argued previously,6 other potential addition
to this analysis is examining the excess body weight as
higher than 25 kg/m2.
The ﬁndings in this study were derived from analysis of
a long-term prospective cohort study with biennial mea-
surements of body weight, covariates and health out-
comes, which enabled us to analyse change in level of
obesity and duration of obesity over a long period. The
analysis takes into account changes in covariates, such as
smoking status, alcohol consumption and physical activ-
ity, and adjusts for a large number of potential confound-
ing variables. However, some potential confounders, such
as diet, were not collected consistently in the FHS and
therefore have not been adjusted for in our analysis.
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Table 2 Characteristics of the study population*
Number Percentage Median Range
p Value†Participant characteristics Total Males Females Total Males Females Total Males Females Total Males Females
Eligible sample 5036 2237 2799 100 44 46
Participants ever obese during study follow-up 1247 494 750 24.7 40 60 0.001
Age at baseline (years) 43 43 43 28–62 29–62 28–62 0.483
Born in the USA 4082 1826 2256 81 44.7 55.3 0.355
Marital status 0.001
Single 452 117 335 9 5 12
Married 4269 2075 2194 85 93 78
Widowed, divorced or separated 315 45 270 6 2 10
Educational level 0.001
Eighth grade or less 1374 616 758 27 28 27
High school 2306 1022 1284 46 46 46
College 752 392 360 15 18 13
Graduate school 604 207 397 12 9 14
Health behaviour
Current smoker at baseline 2583 1435 1154 52 55 45 0.001
Ever-smoker during study follow-up period 3178 1837 1341 63 58 42 0.001
Physical activity score at examination 4 32 33 31 25–83 25–83 25–55 0.001
Alcohol drinking at examination 2, yes, ounces/month‡ 3183 1648 1535 63 52 48 8 15 4 1–360 1–360 1–240 0.001
Body weight characteristics
Body mass index at baseline (kg/m2)§ 25.1 25.6 24.6 16.2–46.3 16.8–38.1 16.2–46.3 0.001
Underweight (<18.5) 65 14 51 1 1 2 0.001
Normal weight (18.5–24.9) 2405 945 1460 48 42 52
Overweight (25–29.9) 1989 1057 932 40 47 33
Obese (≥30) 567 217 350 11 10 13
Cumulative obesity duration (years)¶ 12 10 12 2–46 2–46 2–46 0.001
Cumulative obese-years ¶ 24 15 31 2–556 2–251 2–556 0.001
Cumulative obese-years category¶ 0.001
1–24.9 579 269 319 52 62 45
25–49.9 192 77 115 17 18 17
50–74.9 119 31 87 11 7 13
≥75 233 54 179 21 13 26
CVD (any type) 2753 1375 1378 55 50 50 0.001
Hard CVD 1890 952 938 38 51 49 0.001
Coronary heart disease 1872 1036 836 37 55 45 0.001
Heart attack 1538 920 618 31 60 40 0.001
Myocardial infarction 1105 666 439 22 60 40 0.001
Coronary insufficiency 259 146 113 5 56 44 0.001
Angina pectoris 945 498 447 19 53 47 0.001
Cerebrovascular accident 950 411 539 19 43 57 0.426
Congestive heart failure 876 397 479 17 45 55 0.556
*Participants were free from existing diabetes, CVD and cancer at baseline.
†This p value is for the comparison of males versus females.
‡One ounce≈28.35 g.
§Weight (kg)/height (m)2.
¶For those who were obese during study follow-up.
CVD, cardiovascular disease.
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As has been described elsewhere,6 the limitation of
this analysis might relate to the population being a rela-
tively old cohort study, the FHS that began in 1948; the
prevalence rates of obesity were relatively low at that
time (in the 1950s they were below 10%).19 It could be
argued that the results of this study might not reﬂect
contemporary populations, where the prevalence of
obesity is markedly higher than 50 years ago. In 2008,
the prevalence of obesity among adults in the USA was
more than 30%.20 21 Moreover, the contemporary
obesity epidemic is also characterised by a much earlier
onset of obesity, which could result in even longer expos-
ure by the time today’s obese generation of children
reach the age of our studied cohort. In our study, the
average age at onset of obesity was approximately
50 years, and the average number of years lived with
obesity was approximately 13 years; but in today’s society,
the average age at onset of obesity is likely to be more
than 10 years earlier than in previous decades.22
Nevertheless, our results indicate that the obese-years
metric is still valid and may provide more precision in
predicting the risk of CVD than level of BMI or duration
of obesity alone.
The obese-years metric in this study was based on the
measurement of BMI. It is unclear whether using
anthropometric measures other than BMI would
produce different results. Although, a recent
meta-analysis study has shown that BMI, waist circumfer-
ence (WC) and the waist/hip ratio (WHR) each estimate
a similar risk, particularly for type-2 diabetes23; it is still
worthwhile to explore the relationship between obese-
years and risk of CVD using WC or WHR.
Table 3 Incidence of cardiovascular disease (events/
1000 person-years) according to categories of cumulative
obese-years
Obese-years
categories Events PYFU
Incident rate
(95% CI)
Total population, year
0 2177 116 681 18.66 (17.89 to 19.46)
1–25 276 10 846 25.45 (22.62 to 28.63)
25–50 124 4509 27.50 (23.06 to 32.80)
50–75 78 2365 32.98 (26.42 to 41.18)
≥75 186 4517 41.17 (35.66 to 47.54)
Males, year
0 1138 46 950 24.24 (22.87 to 25.69)
1–25 134 4669 28.70 (24.23 to 34.00)
25–50 56 1710 32.75 (25.21 to 42.56)
50–75 36 720 50.02 (36.08 to 69.34)
≥75 49 951 51.51 (38.93 to 68.16)
Females, year
0 1039 69 731 14.90 (14.02 to 15.83)
1–25 142 6177 22.99 (19.50 to 27.10)
25–50 68 2799 24.30 (19.16 to 30.81)
50–75 42 1645 25.53 (18.87 to 34.54)
≥75 137 3566 38.42 (32.49 to 45.42)
PYFU, person’s years of follow-up.
Table 4 Risk of cardiovascular disease according to categories of obese-years
HR (95% CI)
Total population* Males Females
Model 1
0 obese-years 1 1 1
1–25 obese-years 1.28 (1.13 to 1.45) 1.18 (0.99 to 1.41) 1.37 (1.15 to 1.64)
25–50 obese-years 1.31 (1.09 to 1.57) 1.28 (0.97 to 1.67) 1.40 (1.09 to 1.79)
50–75 obese-years 1.50 (1.21 to 1.85) 1.78 (1.35 to 2.36) 1.46 (1.08 to 1.96)
≥75 obese-years 1.59 (1.36 to 1.85) 1.72 (1.33 to 2.22) 1.78 (1.48 to 2.15)
Dose-response p value 0.001 0.001 0.001
Model 2
0 obese-years 1 1 1
1–25 obese-years 1.26 (1.11 to 1.43) 1.18 (0.99 to 1.41) 1.33 (1.11 to 1.60)
25–50 obese-years 1.32 (1.10 to 1.59) 1.29 (0.99 to 1.70) 1.35 (1.05 to 1.74)
50–75 obese-years 1.55 (1.27 to 1.91) 1.80 (1.36 to 2.38) 1.40 (1.04 to 1.88)
≥75 obese-years 1.74 (1.50 to 2.03) 1.71 (1.32 to 2.21) 1.71 (1.42 to 2.07)
Dose-response p value 0.001 0.001 0.001
Model 3
0 obese-years 1 1 1
1–25 obese-years 1.31 (1.15 to 1.48) 1.22 (1.02 to 1.45) 1.37 (1.14 to 1.65)
25–50 obese-years 1.37 (1.14 to 1.65) 1.39 (1.05 to 1.83) 1.36 (1.05 to 1.76)
50–75 obese-years 1.62 (1.32 to 1.99) 1.89 (1.42 to 2.51) 1.44 (1.08 to 1.94)
≥75 obese-years 1.80 (1.54 to 2.10) 1.81 (1.39 to 2.36) 1.74 (1.44 to 2.10)
Dose-response p value 0.001 0.001 0.001
Model 1 adjusted for age.
Model 2 adjusted for age, marital status, education and country of birth.
Model 3 adjusted for age, marital status, education, country of birth, smoking status, alcohol consumption and physical activity.
*Analyses for total population were adjusted for sex.
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Table 5 The HR of CVD per 10 obese-years
CVD
HR per additional 10 obese-years (95% CI)
Total population* Males Females
CVDs (all types)
Model 1 1.03 (1.02 to 1.04) 1.05 (1.03 to 1.07) 1.03 (1.02 to 1.04)
Model 2 1.03 (1.02 to 1.04) 1.05 (1.03 to 1.07) 1.03 (1.02 to 1.04)
Model 3 1.04 (1.03 to 1.05) 1.06 (1.04 to 1.08) 1.03 (1.02 to 1.04)
Hard CVDs
Model 1 1.03 (1.02 to 1.04) 1.06 (1.04 to 1.08) 1.03 (1.02 to 1.05)
Model 2 1.04 (1.03 to 1.05) 1.06 (1.04 to 1.08) 1.03 (1.02 to 1.04)
Model 3 1.04 (1.03 to 1.05) 1.06 (1.04 to 1.08) 1.03 (1.02 to 1.04)
CHD
Model 1 1.02 (1.01 to 1.03) 1.03 (1.01 to 1.06) 1.03 (1.02 to 1.04)
Model 2 1.03 (1.02 to 1.04) 1.03 (1.01 to 1.06) 1.03 (1.02 to 1.04)
Model 3 1.03 (1.02 to 1.04) 1.04 (1.02 to 1.06) 1.03 (1.02 to 1.04)
CVA
Model 1 1.03 (1.02 to 1.04) 1.06 (1.04 to 1.09) 1.03 (1.01 to 1.04)
Model 2 1.03 (1.02 to 1.04) 1.06 (1.04 to 1.09) 1.02 (1.01 to 1.04)
Model 3 1.03 (1.02 to 1.04) 1.06 (1.04 to 1.09) 1.02 (1.01 to 1.04)
Congestive heart failure (CHF)
Model 1 1.05 (1.03 to 1.06) 1.06 (1.04 to 1.09) 1.05 (1.03 to 1.06)
Model 2 1.05 (1.04 to 1.06) 1.06 (1.04 to 1.09) 1.04 (1.03 to 1.06)
Model 3 1.05 (1.04 to 1.06) 1.06 (1.04 to 1.09) 1.04 (1.03 to 1.06)
Model 1 adjusted for age.
Model 2 adjusted for age, marital status, education and country of birth.
Model 3 adjusted for age, marital status, education, country of birth, smoking status, alcohol consumption and physical activity.
*For total population also adjusted for sex
CHD, coronary heart disease; CVA, cerebrovascular accident; CVD, cardiovascular disease.
Table 6 Comparison of the obese-years metric, BMI and obesity duration as predictors of the risk for CVD
Constructs
AIC
Total population Males Females
CVDs (all types)
Construct 1: level of BMI 43 390 19 227 20 307
Construct 2: duration of obesity 43 379 19 221 20 306
Construct 3: obese-years 43 368 19 209 20 294
Hard CVDs
Construct 1: level of BMI 34 069 15 102 15 976
Construct 2: duration of obesity 34 065 15 099 15 968
Construct 3: obese-years 34 050 15 096 15 955
CHD
Construct 1: level of BMI 29 038 14 355 12 156
Construct 2: duration of obesity 29 039 14 354 12 162
Construct 3: obese-years 29 028 14 351 12 152
CVA
Construct 1: level of BMI 13 575 5211 7147
Construct 2: duration of obesity 13 577 5208 7141
Construct 3: obese-years 13 573 5208 7136
Congestive health failure (CHF)
Construct 1: level of BMI 13 141 5275 6667
Construct 2: duration of obesity 13 122 5263 6663
Construct 3: obese-years 13 104 5255 6649
Each construct was split into 11 categories; 1 represents ‘not obese’ and 2–11 represent deciles of obesity exposure (level, duration and
obese-years).
Each model adjusted for sex, age, marital status, education, smoking, alcohol consumption and physical activity.
AIC, Akaike information criterion; BMI, body mass index; CHD, coronary heart disease; CVA, cerebrovascular accident; CVD, cardiovascular
disease.
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As discussed in our previous study,6 the obese-years
metric was developed based on the assumption that level
and duration of obesity have a similar impact, an
assumption that has been used for the concept of pack-
years in smoking studies. In some smoking studies, it was
highlighted that for certain health outcomes, the effect
of the duration was more important than intensity,24
while in others, duration was not signiﬁcant after adjust-
ment for intensity.25 As we have previously discussed, the
notion that obese-years is only ‘switched on’ when BMI
reaches 30 kg/m2 is crude,6 however, it is an important
construct to consider whether the combination of level
and duration is relevant for a particular outcome. In
addition, although obese-years do ﬁnd a parallel in pack-
years for smoking, which is a construct that ignores any
effects of passive smoking, the nature of cumulative
exposure in obesity is not as straightforward as in
smoking.
These ﬁndings demonstrate that it is important to con-
sider the level of obesity as well as the duration of
obesity and their combination when examining the asso-
ciation between obesity and the risk of chronic disease.
This effect is likely to be because the obese-years metric
takes into account the cumulative damage of obesity to
body systems and consequently is likely to be applicable
to other chronic diseases. However, further investigations
are recommended to be undertaken, of other possible
level/duration constructs of obesity such as considering
the effect of BMI above 25 kg/m2, and of relationships
between obese-years and other chronic diseases, and
mortality.
We acknowledge that a major challenge in examining
the obese-years metric is to have information on the
degree of obesity and the duration of obesity. Few
cohort studies measure obesity and health outcomes
regularly as in the FHS. However, we believe there would
be value in more detailed assessment of height and
weight on multiple repeated occasions in future cohort
studies and to identify other more readily available
proxies of duration, such as peak weight or age of onset
of obesity, and to test to what extent those variables are
equivalent to the obese-year metric.
It is important that these results inform future epi-
demiological analyses, suggesting that the risk of obesity
on some health outcomes is being underestimated if
duration is not being taken into account. This has conse-
quent implications for underestimation of obesity-related
burden of disease modelling and cost-effectiveness ana-
lyses. In addition, the results inform public health policy,
demonstrating further rationale for preventing weight
gain and delaying the onset of obesity.
CONCLUSION
This study demonstrates that the risk of CVD associated
with obesity is derived from the level of obesity attained
and also the length of time lived with obesity. The obese-
years metric conceptually captures the cumulative
damage of obesity on body systems, and is found to
provide slightly more precise estimation of the risk of
CVD than the level or duration of obesity alone.
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